News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
The the Penn Center for Innovation, along with Penn Engineering and Penn Medicine, presented speaker sessions with experts in the field.
Penn spinout Apellis Pharmaceuticals, Inc. received U.S. Food and Drug Administration (FDA) approval for their drug SYFOVRE™ (pegcetacoplan injection).
The Philadelphia Department of Commerce recently issued a $250,000 grant to the Community College of Philadelphia (CCP) for their cell and gene therapy industry lab technician certificate program.
The Fire Awards are PHL Inno’s premiere awards program, showcasing the businesses, institutions and individuals driving the Philadelphia region’s innovation scene forward.
Once completed, the new facility, equipped with next-generation hybrid classrooms and laboratories, will support research in a variety of engineering sectors.
Onocor, a company formed through the UPstart program, has entered into an Amended and Restated License Agreement (ARLA) with Penn to expand its existing license to the ONO medical device.
Katalin Karikó and Drew Weissman received the 2022 Breakthrough Prize Award at a global ceremony hosted by television host James Corden.
Katalin Karikó, PhD, Adjunct Professor of Neurosurgery, was profiled in “Faces of American Innovation,” a report fostered by the Bayh-Dole Act that celebrates the people behind life-changing invention
After receiving CAR T-cell treatment for leukemia in 2012, Emily is now 11 years cancer free, and is heading off to college this fall.
ch of the nine Philadelphia-based cohort companies presented a 5-minute pitch to a live audience, followed by questions and feedback from a panel of judges.